| Date | Description |
|---|
| 2023-09-23 |
delete founder Mark L. Baum |
| 2023-09-23 |
delete otherexecutives Mark L. Baum |
| 2023-09-23 |
delete person Mark L. Baum |
| 2022-03-29 |
insert cfo Ken Owyang |
| 2022-03-29 |
delete index_pages_linkeddomain staging-surfaceophthalmics.com |
| 2022-03-29 |
delete source_ip 34.94.122.55 |
| 2022-03-29 |
insert person Ken Owyang |
| 2022-03-29 |
insert source_ip 162.159.134.42 |
| 2021-05-28 |
insert founder Mark L. Baum |
| 2021-05-28 |
delete management_pages_linkeddomain glaucoma.org |
| 2021-05-28 |
insert person Preeya K. Gupta |
| 2021-05-28 |
update person_description Adrienne L. Graves => Dr. Adrienne Graves |
| 2021-05-28 |
update person_description Mark L. Baum => Mark L. Baum |
| 2021-05-28 |
update person_title Mark L. Baum: Founder and CEO of Imprimis Pharmaceuticals; Director => Founder; Director |